Skip to main content

Research Repository

Advanced Search

Chloride co-transporters as possible therapeutic targets for stroke

Mart�n-Arag�n Baudel, Miguel A. S.; Mart�n-Arag�n Baudel, Miguel A S; Poole, Amy V.; Darlison, Mark G.

Authors

Miguel A. S. Mart�n-Arag�n Baudel

Miguel A S Mart�n-Arag�n Baudel

Mark G. Darlison



Abstract

Stroke is one of the major causes of death and disability worldwide. The major type of stroke is an ischaemic one, which is caused by a blockage that interrupts blood flow to the brain. There are currently very few pharmacological strategies to reduce the damage and social burden triggered by this pathology. The harm caused by the interruption of blood flow to the brain evolves during the following hours and days, so it is critical to identify new therapeutic targets that could reduce the neuronal death associated with the spread of the damage. Here we review some of the key molecular mechanisms involved in the progression of neuronal death, focusing on some new and promising studies. In particular, we focus on the potential of the chloride co-transporter (CCC) family of proteins, mediators of the GABAergic response, both during the early and later stages of stroke, to promote neuroprotection and recovery. Different studies on CCCs, during the chronic and recovery phases post-stroke, reveal the importance of timing when considering CCCs as potential neuroprotective and/or neuromodulator targets. The molecular regulatory mechanisms of the two main neuronal CCCs, NKCC1 and KCC2, are further discussed as an indirect approach to promote neuroprotection and neurorehabilitation following an ischaemic insult. Finally, we mention the likely importance of combining different strategies in order to achieve more effective therapies.

Citation

Martín-Aragón Baudel, M. A. S., Martín-Aragón Baudel, M. A. S., Poole, A. V., & Darlison, M. G. (2017). Chloride co-transporters as possible therapeutic targets for stroke. Journal of Neurochemistry, 140(2), 195-209. https://doi.org/10.1111/jnc.13901

Journal Article Type Article
Acceptance Date Nov 8, 2016
Online Publication Date Dec 22, 2016
Publication Date 2017-01
Deposit Date Nov 18, 2016
Publicly Available Date Dec 23, 2017
Journal Journal of Neurochemistry
Print ISSN 0022-3042
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 140
Issue 2
Pages 195-209
DOI https://doi.org/10.1111/jnc.13901
Keywords brain ischaemia; chloride co-transporter; excitotoxicity; GABAA receptor; neuroprotection; therapy
Public URL http://researchrepository.napier.ac.uk/Output/426239

Files

Chloride co-transporters as possible therapeutic targets for stroke (207 Kb)
Document

Copyright Statement
This is the peer reviewed version of the following article: Martín-Aragón Baudel, M. A. S., Poole, A. V. and Darlison, M. G. (2016), Chloride co-transporters as possible therapeutic targets for stroke. J. Neurochem.. Accepted Author Manuscript. doi:10.1111/jnc.13901, which has been published in final form at http://dx.doi.org/10.1111/jnc.13901. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.


Chloride transporters - Figure 1B (243 Kb)
Other


Chloride transporters - Figure 1A (208 Kb)
Other


Chloride transporters - Figure 2 (244 Kb)
Other


Chloride co-transporters as possible therapeutic targets for stroke (265 Kb)
PDF

Copyright Statement
This is the peer reviewed version of the following article: Martín-Aragón Baudel, M. A. S., Poole, A. V. and Darlison, M. G. (2016), Chloride co-transporters as possible therapeutic targets for stroke. J. Neurochem.. Accepted Author Manuscript. doi:10.1111/jnc.13901, which has been published in final form at http://dx.doi.org/10.1111/jnc.13901. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.





You might also like



Downloadable Citations